BioCentury | Aug 27, 2020
Distillery Therapeutics

Targeting the PP2A-STRN3 interaction to treat gastric cancer

...Fudan University, Shanghai, Chinaemail: zczhou@sibcb.ac.cn Claire Quang Chinese Academy of Sciences Fudan University Protein...
BioCentury | Apr 4, 2020
Product Development

Scripps, HKU structural study keys in on COVID-19 mAb target

...patient and binds the virus’ spike, a protein trimer that mediates host cell entry. A Fudan University...
BioCentury | Apr 3, 2020
Distillery Therapeutics

The bacterial adhesion protein fimH as a cancer immunotherapy adjuvant

...2020 doi:10.1038/s41467-020-15030-4 CONTACT: Jun-O Jin, Fudan University, Shanghai, China; Yeungnam University, Gyeongsan, South Korea email: jinjo@yu.ac.kr Claire Quang Fudan University Bacterial...
BioCentury | Mar 28, 2020
Product Development

COVID-19 diagnostic tech tableau

...landscape PCR in good time The rapid publication of the SARS-CoV-2 RNA genome by a Fudan University-led...
BioCentury | Mar 14, 2020
Translation in Brief

A peptide fusion blocker for multiple coronaviruses, the cryo-EM structure of SARS-CoV-2 main protease, plus Locus, Excision and Harvard-Dana-Farber

...Fudan University develops pan-coronavirus inhibitor A team led by Fudan University researchers has developed a lipopeptide-based pan-coronavirus...
...Nuclear factor (erythroid-derived 2)-like 2 BioCentury Staff Locus Biosciences Inc. Harvard Medical School Dana-Farber Cancer Institute Temple University Excision BioTherapeutics Inc. Fudan University CRISPR-associated...
BioCentury | Feb 26, 2020
Product Development

COVID-19: A growing list of new vaccines and therapies in development

...Inc. Novavax Inc. Sichuan Clover Biopharmaceuticals Inc. CureVac AG Moderna Inc. GeoVax Labs Inc. Baylor College of Medicine University of Texas Medical Branch Fudan University University...
BioCentury | Jan 31, 2020
Clinical News

A dozen vaccine programs under way as WHO declares coronavirus public health emergency

...Inc. Novavax Inc. Sichuan Clover Biopharmaceuticals Inc. CureVac AG Moderna Inc. GeoVax Labs Inc. Baylor College of Medicine University of Texas Medical Branch Fudan University University...
BioCentury | Jan 25, 2020
Product Development

The race is on to develop therapies and vaccines for the coronavirus outbreak

...Dec. 30, China reported the outbreak to the WHO on Dec. 31, and researchers at Fudan University...
...University of Texas Medical Branch, the New York Blood Center and the Virology Center at Fudan University...
...Gates Foundation Moderna Therapeutics Inc. Inovio Pharmaceuticals Inc. University of Queensland CureVac AG Codagenix Inc. Novavax Inc. Texas Children's Hospital Baylor College of Medicine Fudan University Wuhan...
BioCentury | Jan 23, 2020
Clinical News

Biopharma companies, academics, governments racing to develop medical countermeasures against novel coronavirus

...University of Texas Medical Branch, the New York Blood Center and the Virology Center at Fudan University...
BioCentury | Dec 6, 2019
Targets & Mechanisms

A view of immune reprogramming from ASH

...the disease is associated with higher proportions of M1 macrophages ( No. 2317 ). A Fudan University...
...Compound #), ruxolitinib (Generic), Jakavi (Other), Jakafi (Other) pevonedistat (MLN4924, TAK-924) American Society of Hematology Takeda Pharmaceutical Co. Ltd. Fudan University National...
Items per page:
1 - 10 of 65
BioCentury | Aug 27, 2020
Distillery Therapeutics

Targeting the PP2A-STRN3 interaction to treat gastric cancer

...Fudan University, Shanghai, Chinaemail: zczhou@sibcb.ac.cn Claire Quang Chinese Academy of Sciences Fudan University Protein...
BioCentury | Apr 4, 2020
Product Development

Scripps, HKU structural study keys in on COVID-19 mAb target

...patient and binds the virus’ spike, a protein trimer that mediates host cell entry. A Fudan University...
BioCentury | Apr 3, 2020
Distillery Therapeutics

The bacterial adhesion protein fimH as a cancer immunotherapy adjuvant

...2020 doi:10.1038/s41467-020-15030-4 CONTACT: Jun-O Jin, Fudan University, Shanghai, China; Yeungnam University, Gyeongsan, South Korea email: jinjo@yu.ac.kr Claire Quang Fudan University Bacterial...
BioCentury | Mar 28, 2020
Product Development

COVID-19 diagnostic tech tableau

...landscape PCR in good time The rapid publication of the SARS-CoV-2 RNA genome by a Fudan University-led...
BioCentury | Mar 14, 2020
Translation in Brief

A peptide fusion blocker for multiple coronaviruses, the cryo-EM structure of SARS-CoV-2 main protease, plus Locus, Excision and Harvard-Dana-Farber

...Fudan University develops pan-coronavirus inhibitor A team led by Fudan University researchers has developed a lipopeptide-based pan-coronavirus...
...Nuclear factor (erythroid-derived 2)-like 2 BioCentury Staff Locus Biosciences Inc. Harvard Medical School Dana-Farber Cancer Institute Temple University Excision BioTherapeutics Inc. Fudan University CRISPR-associated...
BioCentury | Feb 26, 2020
Product Development

COVID-19: A growing list of new vaccines and therapies in development

...Inc. Novavax Inc. Sichuan Clover Biopharmaceuticals Inc. CureVac AG Moderna Inc. GeoVax Labs Inc. Baylor College of Medicine University of Texas Medical Branch Fudan University University...
BioCentury | Jan 31, 2020
Clinical News

A dozen vaccine programs under way as WHO declares coronavirus public health emergency

...Inc. Novavax Inc. Sichuan Clover Biopharmaceuticals Inc. CureVac AG Moderna Inc. GeoVax Labs Inc. Baylor College of Medicine University of Texas Medical Branch Fudan University University...
BioCentury | Jan 25, 2020
Product Development

The race is on to develop therapies and vaccines for the coronavirus outbreak

...Dec. 30, China reported the outbreak to the WHO on Dec. 31, and researchers at Fudan University...
...University of Texas Medical Branch, the New York Blood Center and the Virology Center at Fudan University...
...Gates Foundation Moderna Therapeutics Inc. Inovio Pharmaceuticals Inc. University of Queensland CureVac AG Codagenix Inc. Novavax Inc. Texas Children's Hospital Baylor College of Medicine Fudan University Wuhan...
BioCentury | Jan 23, 2020
Clinical News

Biopharma companies, academics, governments racing to develop medical countermeasures against novel coronavirus

...University of Texas Medical Branch, the New York Blood Center and the Virology Center at Fudan University...
BioCentury | Dec 6, 2019
Targets & Mechanisms

A view of immune reprogramming from ASH

...the disease is associated with higher proportions of M1 macrophages ( No. 2317 ). A Fudan University...
...Compound #), ruxolitinib (Generic), Jakavi (Other), Jakafi (Other) pevonedistat (MLN4924, TAK-924) American Society of Hematology Takeda Pharmaceutical Co. Ltd. Fudan University National...
Items per page:
1 - 10 of 65